David Schenkein – Biografia

David foi Senior Vice President, Clinical Hematology/Oncology para a Genentech, e Senior Vice President, Clinical Research and Development da Millennium Pharmaceuticals. David foi Chief Executive Officer da Flagship Pioneering.

David Schenkein atualmente é

• General Partner and Co-Head of Life Science at GV - View - GV org chart

• Board Director at Aera Therapeutics - View - Aera Therapeutics org chart

• Director at Delphia Therapeutics - View - Delphia Therapeutics org chart

• Director at Denali Therapeutics - View - Denali Therapeutics org chart

• Director at Leyden Labs - View - Leyden Labs org chart

• Director at Prime Medicine - View - Prime Medicine org chart

• Director at Regeneron Pharmaceuticals - View - Regeneron Pharmaceuticals org chart

Criar um alerta
para seguir a carreira de David Schenkein.

David Schenkein é um Bachelor of Arts in Chemistry pela Wesleyan University e um Doctor of Medicine pela State University of New York Medical University .

Eles também estudaram em Wesleyan University:

• Scott Gottlieb - Pfizer

• Desiree Ralls-Morrison - McDonald's

• Maria Poveromo - Cisco

Encontre 0a Wesleyan University

Aqui estão algumas sugestões para fazer contato com sucesso.